2019
ANTIDEPRESSANTS FOR ANXIETY DISORDERS IN LATE-LIFE: A SYSTEMATIC REVIEW
Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, Gupta A, Young J, Tampi R. ANTIDEPRESSANTS FOR ANXIETY DISORDERS IN LATE-LIFE: A SYSTEMATIC REVIEW. American Journal Of Geriatric Psychiatry 2019, 27: s125. DOI: 10.1016/j.jagp.2019.01.076.Peer-Reviewed Original ResearchSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsUse of antidepressantsTolerability of antidepressantsLate-life anxietySystematic reviewAnxiety disordersOlder adultsReuptake inhibitorsTreatment optionsTricyclic antidepressantsCognitive impairmentFirst-line pharmacological treatmentLate-life anxiety disordersVariable drug absorptionLong-term tolerabilityEfficacy of antidepressantsEfficacious treatment optionSerotonin reuptake inhibitorsPrevention of relapseCochrane Collaboration databasesTrial of paroxetineLate-life GADLater lifeVolume of distribution
2015
Acetylcholinesterase Inhibitors for Delirium in Older Adults
Tampi RR, Tampi DJ, Ghori AK. Acetylcholinesterase Inhibitors for Delirium in Older Adults. American Journal Of Alzheimer's Disease & Other Dementias® 2015, 31: 305-310. PMID: 26646113, PMCID: PMC10852606, DOI: 10.1177/1533317515619034.Peer-Reviewed Original ResearchConceptsManagement of deliriumActive drug groupOlder adultsHospital stayAcetylcholinesterase inhibitorsDrug groupsIncidence of deliriumCochrane Collaboration databasesPlacebo groupDeliriumCurrent evidenceMortality rateSystematic reviewLiterature searchAdditional studiesStatistical significanceLonger durationAdultsLonger lengthRCTsHaloperidolStayInhibitorsPreventionBibliographic databases
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply